Pharmac - Supply Update
- admin82291
- 12 hours ago
- 2 min read

New medicine supply notices
Frumil (amiloride and furosemide): Discontinuation (Pharmacode: 2125536) The supplier is discontinuing Frumil tablets. This is a global discontinuation. Supplies are likely to run out in February 2026. A flyer is available to support conversations with affected people.
Mometasone furoate (Elocon) Oint 0.1% 50 g pack (Pharmacode: 2395746) Because of recent unusually high sales, the supplier is out of stock of the Elocon ointment 50 g pack. All other presentations of mometasone remain available, including the 15 g ointment, the cream, and the lotion.
Updated medicine supply notices
Isoniazid 100 mg with rifampicin 150 mg (Rifinah 100/150) tablets (Pharmacode: 251232) The alternative combination product has arrived. It was shipped to wholesalers yesterday. It will still take time to get through the supply chain to pharmacies.
Concerta: All strengths available
Ritalin: All strengths available
Rubifen: All strengths available, except 20 mg immediate release
Sandoz XR: Funded from 1 December, available by mid-December
Teva: All strengths available, except 27 mg.
Nonacog gamma [Recombinant Factor IX] (Rixubis) Inj 2,000 iu vial (Pharmacode: 2487950) The resupply for this product has been delayed to mid-December 2025. It may take another 1 to 2 weeks to reach pharmacies after that time.
Norimin 84 pack Image added showing a side-by-side comparison of the New Zealand pack (Pharmacode 410691) and the Australian pack (Pharmacode: 2636077).
Oxytocin (inj 10 iu per ml) (Pharmacode: 2577046) The German alternate should now be available to order. We are working with the supplier to understand when the NZ product will be available again.
Sodium Fusidate [fusidic acid] (Fucithalmic) Eye drops 1% (Pharmacode: 716634) The Fucithalmic brand of eyedrops has been registered.
Resolved issues
Desmopressin acetate (Desmopressin-PH&T) Nasal spray (Pharmacode: 2702916).
Note: Supply issues are marked as resolved one week after when the supplier has product available. It can take another 1 to 2 weeks for stock to reach pharmacies around the motu.
Recent decisions and open consultations
Proposal to fund a new strength of thiamine hydrochloride injection (closes 15 December)
Proposal to widen access to bortezomib for the treatment of Waldenström’s macroglobulinemia (closes 16 December)
Improving access to treatments in the community for trauma and medical emergencies, and ketamine for palliative care (closes 19 December)
2025/26 Invitation to Tender (Closes 15 December 2025)
